Monoclonal antibody therapy for CD-20 positive non-Hodgkin lymphoma: EGE university experience

dc.contributor.authorDemirag, Benu
dc.contributor.authorCetingul, Nazan
dc.contributor.authorKantar, Mehmet
dc.contributor.authorAksoylar, Serap
dc.contributor.authorsoy, Savas Kan
dc.contributor.authorHekimgil, Mine
dc.date.accessioned2019-10-27T20:01:45Z
dc.date.available2019-10-27T20:01:45Z
dc.date.issued2007
dc.departmentEge Üniversitesien_US
dc.identifier.endpage474en_US
dc.identifier.issn1545-5009
dc.identifier.issue4en_US
dc.identifier.startpage474en_US
dc.identifier.urihttps://hdl.handle.net/11454/41285
dc.identifier.volume49en_US
dc.identifier.wosWOS:000249116100286en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherWiley-Lissen_US
dc.relation.ispartofPediatric Blood & Canceren_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleMonoclonal antibody therapy for CD-20 positive non-Hodgkin lymphoma: EGE university experienceen_US
dc.typeConference Objecten_US

Dosyalar